BioNTech SE (BNTX)
110.14
-0.28
(-0.25%)
USD |
NASDAQ |
Feb 20, 16:00
110.29
+0.14
(+0.13%)
After-Hours: 20:00
BioNTech SG&A Expense (Quarterly) : 173.54M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| CureVac NV | 29.72M |
| Merck & Co., Inc. | 2.898B |
| Novavax, Inc. | 31.66M |
| Pfizer Inc. | 4.162B |
| Moderna, Inc. | 308.00M |